An observational study of inflammation in the central nervous system in patients with bipolar disorder

Bipolar Disorders

Volumn 17, Issue 3, 2015, Pages 291-302

  Stich, Oliver ^a   Andres, Tamara A ^a   Gross, Claus M ^a   Gerber, Sonja I ^a   Rauer, Sebastian ^a,b   Langosch, Jens M ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b RAVO DIAGNOSTIKA GMBH   (Germany)

^c Bethanien Hospital for Psychiatry   (Germany)

Author keywords

Toxoplasma gondii; Antibodies; Antibody index; Bipolar disorder; Cerebrospinal fluid; Cytomegalovirus; Epstein Barr virus; Herpes simplex; Herpesviridae; Infection; Intrathecal synthesis; Neurotropic agents

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY; VIRUS ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ARTICLE; BIPOLAR DISORDER; BRAIN PSEUDOTUMOR; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MALE; NERVOUS SYSTEM INFLAMMATION; OBSERVATIONAL STUDY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SEROPREVALENCE; TOXOPLASMA GONDII; CASE CONTROL STUDY; CEREBROSPINAL FLUID; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; MIDDLE AGED; TOXOPLASMA;

ADULT; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CYTOMEGALOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HERPESVIRUS 4, HUMAN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; TOXOPLASMA;

EID: 84928161267     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12244     Document Type: Article

References (37)

1. Price AL, Marzani-Nissen GR. Bipolar disorders: a review. Am Fam Physician 2012; 85: 483-493.
2. Shih RA, Belmonte PL, Zandi PP. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 2004; 16: 260-283.
3. Escamilla MA, Zavala JM. Genetics of bipolar disorder. Dialogues Clin Neurosci 2008; 10: 141-152.
4. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
5. Hamdani N, Tamouza R, Leboyer M. Immuno-inflammatory markers of bipolar disorder: a review of evidence. Front Biosci 2012; 4: 2170-2182.
6. Söderlund J, Olsson SK, Samuelsson M et al. Elevation of cerebrospinal fluid interleukin-1β in bipolar disorder. J Psychiatry Neurosci 2011; 36: 114-118.
7. Jakobsson J, Stridsberg M, Zetterberg H et al. Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder. J Psychiatry Neurosci 2013; 38: E21-E26.
8. Leboyer M, Soreca I, Scott J et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 2012; 141: 1-10.
9. Nery FG, Monkul ES, Hatch JP et al. Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Hum Psychopharmacol 2008; 23: 87-94.
10. Drexhage RC, Hoogenboezem TH, Versnel MA, Berghout A, Nolen WA, Drexhage HA. The activation of monocyte and T cell networks in patients with bipolar disorder. Brain Behav Immun 2011; 25: 1206-1213.
11. Drexhage RC, Knijff EM, Padmos RC et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 2010; 10: 59-76.
12. Dickerson F, Stallings C, Origoni A, Vaughan C, Khushalani S, Yolken R. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder. J Affect Disord 2013; 150: 456-459.
13. Suvisaari J, Mantere O. Inflammation theories in psychotic disorders: a critical review. Infect Disord Drug Targets 2013; 13: 59-70.
14. Rege S, Hodgkinson SJ. Immune dysregulation and autoimmunity in bipolar disorder: synthesis of the evidence and its clinical application. Aust N Z J Psychiatry 2013; 47: 1136-1151.
15. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8: 131-145.
16. Yolken RH, Torrey EF. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 2008; 13: 470-479.
17. Tedla Y, Shibre T, Ali O et al. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 2011; 49: 211-220.
18. Hamdani N, Daban-Huard C, Lajnef M et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord 2013; 148: 444-448.
19. Gerber SI, Krienke UJ, Biedermann NC et al. Impaired functioning in euthymic patients with bipolar disorder-HSV-1 as a predictor. Prog Neuropsychopharmacol Biol Psychiatry 2012; 36: 110-116.
20. Jones-Brando L, Torrey EF, Yolken RH. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003; 62: 237-244.
21. Pearce BD, Kruszon-Moran D, Jones JL. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiatry 2012; 72: 290-295.
22. Mortensen PB, Pedersen CB, McGrath JJ et al. Neonatal antibodies to infectious agents and risk of bipolar disorder: a population-based case-control study. Bipolar Disord 2011; 13: 624-629.
23. Hamdani N, Doukhan R, Picard A, Tamouza R, Leboyer M. A bipolar disorder patient becoming asymptomatic after adjunctive anti-filiarasis treatment: a case report. BMC Psychiatry 2013; 13: 81.
24. Webster JP, Lamberton PH, Donnelly CA, Torrey EF. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stablizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 2006; 273: 1023-1030.
25. Dickerson FB, Boronow JJ, Stallings C et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 2004; 55: 588-593.
26. Dickerson FB, Boronow JJ, Stallings C et al. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar Disord 2006; 8: 124-132.
27. Torrey EF, Yolken RH, Winfrey CJ. Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science 1982; 216: 892-894.
28. Carter CJ. Susceptibility genes are enriched in those of the HSV-1/host interactome in psychiatric and neurological disorders. Pathog Dis 2013; 69: 240-261.
29. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997; 28: 1-38.
30. Delgado García G, Rodríguez Perdomo E. [Reactivity of toxoplasmin intradermal test in neurotic and manic-depressive patients]. Rev Cubana Med Trop 1980; 32: 35-39.
31. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001; 184: 101-122.
32. Reiber H, Ungefehr S, Jacobi C. The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 1998; 4: 111-117.
33. Carter CJ. Toxoplasmosis and polygenic disease susceptibility genes: extensive Toxoplasma gondii host/pathogen interactome enrichment in nine psychiatric or neurological disorders. J Pathog 2013; 2013: 965046.
34. Rowse A, Naves R, Cashman K et al. Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling. PLoS ONE 2012; 7: e52658.
35. Knijff EM, Breunis MN, Kupka RW et al. An imbalance in the production of IL-1β and IL-6 by monocytes of bipolar patients: restoration by lithium treatment. Bipolar Disord 2007; 9: 743-753.
36. Padmos RC, Bekris L, Knijff EM et al. A high prevalence of organ-specific autoimmunity in patients with bipolar disorder. Biol Psychiatry 2004; 56: 476-482.
37. Eaton WW, Pedersen MG, Nielsen PR, Mortensen PB. Autoimmune diseases, bipolar disorder, and non-affective psychosis. Bipolar Disord 2010; 12: 638-646.